Recently, Guangzhou Boji Pharmaceutical Biotechnology Co., Ltd. issued an announcement that the company intends to acquire Shenzhen Huarong Sheng Technology Co., Ltd. held by Hong Kong Yonghe Technology Co., LTD44%Shares of approximately4,800Upon completion of the acquisition, Boji Pharmaceutical will hold Hong Kong Yonghe95%Shares of Boji is a one-stop outsourcing service for the whole process of R&D and production of medicines, medical devices and health products for domestic and foreign pharmaceutical enterprises.CRO+CDMO) new high-tech enterprises.

Hong Kong Wing Wo is one of the largest companies in Hong Kong2016Established in 2007, the main business of the pharmaceutical enterprise is the research and development of pharmaceutical products. The objective of the acquisition is to help the company further strengthen its control over its holding companies, optimize its collaborative business processes, and fully implement its corporate growth strategy.

CycloseThe company focuses on providing corporate audit, tax declaration, registration, annual inspection, tax planning and other services in Hong Kong, Singapore, Dubai and other regions. Efficient, rigorous, intimate service has been favored by many private enterprises, listed companies and large state-owned enterprises.